Ken Herrmann, MD, received the medical degree in 2004 from Charité Berlin (Germany), after studying also at Université de Lausanne (Switzerland), Universidad Austral (Chile) and Memorial-Sloan Kettering Cancer Center (USA). He completed residency training in nuclear medicine at the Technische Universität München. Meanwhile, he performed a fellowship at Hokkaido University (Japan) and received an executive MBA degree from the University of Zürich (Switzerland). Since 2011, Dr. Herrmann has held a faculty position at the Department of Molecular and Medical Pharmacology of the University of California Los Angeles (USA). He is currently Vice Chair of the Nuclear Medicine Department at Universitätsklinikum Würzburg (Germany). He focuses on close collaborations with clinical partners in the field of neurology and oncology.